Kahaly, George J.; Gottwald-Hostalek, Ulrike
Use of levothyroxine in the management of hypothyroidism: A historical perspectiveFRONTIERS IN ENDOCRINOLOGY. Bd. 13. 2022
Schattenberg, Joern; Alkhouri, Naim; Taub, Rebecca et al.
Utility of FIB-4 thresholds to identify patients with at-risk F2-F3 NASH based on screening data from a 2000 patient biopsy confirmed cohort of resmetirom Phase 3 clinical trial, MAESTRO-NASHJOURNAL OF HEPATOLOGY. Bd. 77. 2022 S. S75-S75
Kaps, Leonard; Hildebrand, Katharina; Nagel, Michael et al.
Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosisCLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. Bd. 46. H. 4. 2022
McNamara, Mairead G.; Bridgewater, John; Goyal, Lipika et al.
What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)?-a retrospective review of the published literatureBMJ OPEN. Bd. 12. H. 10. 2022
Bednarczuk, Tomasz; Brix, Thomas H.; Schima, Wolfgang et al.
2021 European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid DysfunctionEUROPEAN THYROID JOURNAL. Bd. 10. H. 4. 2021 S. 269-284
Diana, Tanja; Ungerer, Martin; Wuster, Christian et al.
A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves' disease mouse modelJOURNAL OF AUTOIMMUNITY. Bd. 122. 2021
Moehler, Markus; Michel, Maurice; Stein, Alexander et al.
A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancerFUTURE ONCOLOGY. Bd. 17. H. 25. 2021 S. 3309-3319
Sangro, Bruno; Harding, James J.; Johnson, Matthew et al.
A phase III, double-blind, randomized study of nivolumab (NIVO) and ipilimumab (IPI), nivo monotherapy or placebo plus transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 3. 2021
Schattenberg, Jorn M.; Pares, Albert; Kowdley, Kris V. et al.
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCAJOURNAL OF HEPATOLOGY. Bd. 74. H. 6. 2021 S. 1344-1354
Francque, Sven M.; Bedossa, Pierre; Ratziu, Vlad et al.
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASHNEW ENGLAND JOURNAL OF MEDICINE. Bd. 385. H. 17. 2021 S. 1547-1558